FDA Licensing Studies Prove PRASCEND® (pergolide mesylate) Safety1,2

Safe for use in horses

PRASCEND is not only safe, effective, and a good value—it’s also easy to give to your horse. Your veterinarian determine out the right dose for your horse and give you specific directions. PRASCEND tablets and packaging are designed to make administration easier for you and your horse!

For your added peace of mind, more safety checks were done during a large effectiveness study, which took place in real-life settings throughout the country.1,2 Results of this study showed that PRASCEND is safe to use in horses to reduce the effects of PPID when you treat your horse with PRASCEND under guidance from your veterinarian.1,2

A 6-month study done in real-world situations showed PRASCEND was safe to use in horses to control common signs of PPID. PRASCEND tablets were given once daily at up to 2 times the normal amount to 32 Paint and Appaloosa horses ranging from 3 to 10 years of age.

Simple to use

Convenient, scored PRASCEND tablets are easy to give. Just don’t crush the tablet or you could be exposed to its effects. Instead, you can put an undissolved tablet in an apple or other treat for your horse. Or simply dissolve the tablet in water, mix with your horse’s favorite sweetener, such as molasses, if you’d like. Then either squirt the liquid into your horse’s mouth or on top of his feed. That’s all there is to it!

  • Each tablet contains 1 mg of pergolide mesylate, so you always know how much you're giving.
  • Packaged in convenient 10-tablet blister cards (plastic pockets sealed with aluminum foil).
  • Blister cards are packaged in cartons containing either 60 or 160 tablets, so you can pick whichever size works best for you!

A good value

For about the cost of one cup of coffee per day, PRASCEND will help your horse control the clinical signs associated with PPID. Include in your horse’s normal routine as a daily treat, to help relieve your horse of the signs of PPID.

Important safety information

PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. Weight loss, lack of energy, and behavioral changes also may be observed. If severe, a temporary dose reduction may be necessary. PRASCEND has not been evaluated in breeding, pregnant, or lactating horses and may interfere with reproductive hormones in these horses. Using PRASCEND at the same time as drugs known as dopamine antagonists should be avoided. These drugs may diminish the effectiveness of PRASCEND. If your horse is especially sensitive to pergolide mesylate or similar products, PRASCEND should not be used. Refer to the package insert for complete product information.

References:

  1. PRASCEND® (pergolide mesylate) [package insert]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011.
  2. PRASCEND® (pergolide mesylate) [Freedom of Information Summary]. St Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011.